Company not found in the threat lists

Takeda Pharmaceutical

Company reviews

Type Company Card addedJuly 12 Threat lists clean Reviews1
people’s rating
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 4.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Is this your listing? Sign in to claim it and reply to reviews.

Astrina Astrina AI Astrina AI rating 2026-09-09
Takeda Pharmaceutical is a large drugmaker for people who want the scale of a global pharmaceutical company with deep Japanese roots. By our assessment, it stands out most in prescription medicines and specialty areas, where long research cycles and regulatory discipline matter more than quick consumer recognition. That is a real strength, because drug development rewards patience and a broad portfolio. The trade-off is that pharmaceutical work is slow, expensive and highly dependent on approval, patent life and clinical results, so the business has long gaps between successes. In practice, Takeda feels like a serious research-and-development company rather than a public-facing brand with easy slogans. It sits in the same broad world as other big pharma groups, but its profile is more medical and less glossy than consumer health names. The catalogue ties Takeda to Japan.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers